Search clinical trials for: ABY-029

Total 9500 results

Ably Medical AS
Alesund Hospital

Enrolling by invitation

LYNG21: Ably LYNG Clinical Demonstration in Operative Environment (LYNG21)

Monitoring, Physiologic

Norway
University Hospital Tuebingen

Recruiting

Early Antibiotic Therapy and Vaccinations in Preterm Infants

Vaccination Reaction

Germany
Instituto Mexicano del Seguro Social
Massachusetts General Hospital; Fundacion Rio Arronte

Active, not recruiting

Educational Intervention in the First 18 Months of Life to Prevent/Manage Obesity of Children After Gestational Diabetes

Overweight and Obesity | Gestational Diabetes

Mexico
Addpharma Inc.

Completed

A Study to Evaluate the Efficacy and Safety of AD-209

Hypertension, Essential

Korea, Republic of
Alexza Pharmaceuticals, Inc.

Completed

Staccato Apomorphine Single and Multi Dose PK

Parkinson Disease

Netherlands
ViiV Healthcare
GlaxoSmithKline

Completed

PRJ2203: Dolutegravir Post Authorization Safety Study (PASS)

Infection, Human Immunodeficiency Virus I
Millennium Pharmaceuticals, Inc.

Completed

A Study to Evaluate the Safety, Pharmacokinetics (PK), and Pharmacodynamics (PD) of TAK-079 in Combination With Standard Background Therapy in Participants With Moderate to Severe Systemic Lupus Erythematosus (SLE)

Systemic Lupus Erythematosus | Lupus Erythematosus, Systemic

United States
Alexza Pharmaceuticals, Inc.

Completed

Staccato Apomorphine Multi-dose PK and PD in Patients With Parkinson's Disease

Parkinson's Disease

Netherlands
Novo Nordisk A/S

Completed

A Research Study Investigating NNC0247-0829 for Weight Management in People With Overweight or Obesity

Obesity | Overweight

United States
Charite University, Berlin, Germany

Completed

Chronic, Low Dose Erythropoetin Beta in Ischemic Cardiomyopathy (EPOHeart)

Ischemic Cardiomyopathy

Germany
Arcturus Therapeutics, Inc.

Completed

Ascending Dose Study of Investigational SARS-CoV-2 Vaccine ARCT-021 in Healthy Adult Subjects

SARS-CoV-2

Singapore
Tianjin Medical University General Hospital

Recruiting

Normal Saline Infusion for Stroke After Intravenous Thrombolysis (NS-STAR)

Brain Infarct

China
Nanjing Leads Biolabs Co.,Ltd

Recruiting

A Phase I/II Clinical Study of LBL-024 in Patients With Advanced Malignant Tumors

Advanced Solid Tumor

China
Kainos Medicine Inc.

Completed

Single Ascending Dose (SAD)/Multiple Ascending Dose(MAD) Safety/Pharmacokinetic (PK) Study of KM-023

Human Immunodeficiency Virus

Korea, Republic of
Fluart Innovative Vaccine Ltd, Hungary

Completed

Tolerability and Immunogenicity Study of FLUVAL P H1N1 Flu Vaccine of Omninvest in Children and Adolescents

Influenza, Human | Novel 2009 Influenza H1N1

Hungary
YourChoice Therapeutics, Inc.

Recruiting

First in Human Study Evaluating Single Ascending Oral Doses of YCT-529 in Healthy Males

Male Contraception

United Kingdom
Takeda

Completed

A Study of TAK-079 in People With Generalized Myasthenia Gravis

Myasthenia Gravis

United States, Spain, Canada, Serbia, Italy, Poland
Merck Sharp & Dohme LLC

Completed

Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of MK-1029 in Participants With Mild to Moderate Asthma

Asthma

United States, Australia, New Zealand, South Africa
Merck Sharp & Dohme LLC

Completed

A Two-part Study of the Effects of MK-1029 in Allergen-Challenged Asthmatics (MK-1029-003)

Asthma
Takeda

Completed

TAK-020 Relative Bioavailability and Food Effect Study in Healthy Participants

Healthy

United Kingdom
Suzhou Yabao Pharmaceutical R&D Co., Ltd.

Completed

Multiple Ascending Doses of SY-009 in Type 2 Diabetes Mellitus

Type 2 Diabetes Mellitus

China
Carmel Medical Center

Unknown

IV NaCl (Sodium Chloride) 0.9% Vs (Versus) IV NaCl 0.9% + 5% Dextrose in Pediatric ER for Dehydration

Dehydration

Israel
Ahmad Jabir Rahyussalim

Unknown

Effectivity of Mesenchymal Stem Cell on Vertebral Bone Defect Due to Mycobaterium Tuberculosis Infection

Mesenchymal Stem Cell | Spinal Tuberculosis

Indonesia
University Hospital, Caen

Recruiting

Markers of Executive Attention Development in Preschoolers - Behavioral Measures in Various Populations (MEDiATE-PRV)

Attention Deficit

France
TC Erciyes University

Completed

Effect of Massage Therapy on Severity of Restless Legs Syndrome and Quality of Life in Hemodialysis Patients

Hemodialysis

Turkey
Oslo University Hospital
University of Oslo; Norwegian University of Science and Technology; St. Olavs... and other collaborators

Completed

ASSessing the Effect of Anti-IL-6 Treatment in Myocardial Infarction: The ASSAIL-MI Trial (ASSAIL-MI)

Myocardial Infarction | Coronary Disease

Norway
Aydin Adnan Menderes University

Completed

Effects of Fluid Infusion on Postoperative Vomiting in Pediatric Patients Undergoing Otorhinolaryngological Surgery (FLUIDVOMIT)

Postoperative Nausea and Vomiting

Turkey
Asmacure Ltée

Completed

Safety, Tolerability and Clinical Activity of ASM-024 in Stable Moderate Asthma

Asthma

Canada
ACELYRIN Inc.

Completed

A Study to Investigate Efficacy, Tolerability and Safety of ABY-035 in Patients With Active Psoriatic Arthritis

Psoriatic Arthritis

Poland, Hungary, Germany, Belgium, Czechia, Austria, Spain
Foresee Pharmaceuticals Co., Ltd.

Completed

The Effect of FP-025, on Allergen-induced Airway Responses in Mild Eosinophilic House Dust Mite (HDM)-Allergic Asthma.

Asthma, COPD

Netherlands
Ottawa Hospital Research Institute

Completed

Crystalloid FLUID Choices for Resuscitation of Hospitalized Patients (FLUID)

Fluid Therapy

Canada
Sanofi
Regeneron Pharmaceuticals

Completed

Proof-of-Concept Study to Assess the Efficacy, Safety and Tolerability of SAR440340 (Anti-IL-33 mAb) in Patients With Moderate-to-severe Chronic Obstructive Pulmonary Disease (COPD)

Chronic Obstructive Pulmonary Disease

Ukraine, Argentina, Chile, Poland, Russian Federation, Turkey, United States, Australia, Canada, Germany
Affibody
TFS Trial Form Support

Completed

A Study to Evaluate ABY-035 in Subjects With Moderate-to-severe Plaque Psoriasis (AFFIRM-35)

Plaque Psoriasis

Germany
ParaPRO LLC
Concentrics Research

Completed

Phase 3 Trial to Assess the Safety and Efficacy of Natroba for the Treatment of Scabies

Scabies

United States
ParaPRO LLC
Concentrics Research

Completed

Phase 3 Trial to Assess the Safety and Efficacy of Natroba for the Treatment of Scabies

Scabies

United States
Tri-Service General Hospital

Completed

Fluid Restriction After Stapled Hemorrhoidopexy

Fluid Restriction

Taiwan
Region Skane

Completed

Importance of Restoring Biomechanical Correct Hip Anatomy During Total Hip Arthroplasty

Osteoarthritis

Sweden
Alkermes, Inc.
QPS Netherlands B.V.

Completed

Single and Multiple Ascending Dose and Food Effect PK Study in Healthy Adult and Elderly Subjects

Healthy

Netherlands
Bayer
Amgen

Withdrawn

GIDEON Non-Nexavar Arm - HCC Patients Who Are Treated With Any Therapy Other Than Nexavar at Individual Study Start

Carcinoma, Hepatocellular

United States
ResoTher Pharma

Recruiting

An Exploratory, Randomised, Double-blind Study of RTP-026 to Assess Safety, Tolerability and Efficacy in Patients With ST-Elevation Myocardial Infarction (STEMI)

ST Elevation Myocardial Infarction

Denmark
Humedix Co., Ltd.

Recruiting

Efficacy and Safety of HMM1-022 in Temporary Correction of Crow's Feet

Crows Feet

Korea, Republic of
Suzhou Puhe Pharmaceutical Technology Co., LTD

Recruiting

Assessing an Oral EGFR Inhibitor,YK-209A in Patients Who Have Advanced Non-small Cell Lung Cancer With EGFR

Treatment Side Effects | Treatment

China
Children's Hospital Medical Center, Cincinnati
National Institutes of Health (NIH)

Recruiting

Improving Outcomes in Pediatric Obstructive Sleep Apnea With Computational Fluid Dynamics (OSA-MRI)

Obstructive Sleep Apnea

United States
Agomab Spain S.L.

Completed

Relative Bioavailability and Effect of Food Study With AGMB-129 in Healthy Participants

Healthy Volunteers

Belgium
Beijing InnoCare Pharma Tech Co., Ltd.

Completed

A Study of ICP-022 in Patients With R/R DLBCL (DLBCL)

Diffuse Large B Cell Lymphoma

China
Beijing InnoCare Pharma Tech Co., Ltd.

Completed

A Study of ICP-022 in the Treatment of Recurrent or Refractory Waldenstrom Macroglobulinemia

Waldenstrom's Macroglobulinemia Recurrent | Waldenstrom's Macroglobulinemia Refractory

China
Takeda

Completed

A Single Heterologous Booster Vaccination Study of TAK-019 in Healthy Japanese Adults (COVID-19)

Coronavirus Disease (COVID-19)

Japan
DermBiont, Inc.
Zepeda Dermatologia

Active, not recruiting

Adaptive Design Study for Safety and Efficacy of Treatment Regimens With SM-020 in Subjects With Seborrheic Keratosis

Seborrheic Keratosis

El Salvador
Optinose US Inc.

Terminated

A Study to Evaluate Change in Viral Load After OPN-019 in Adults With COVID-19

Covid19

Mexico
Palvella Therapeutics, Inc.

Active, not recruiting

VALO-2: Study Evaluating the Safety and Efficacy of PTX022 in the Treatment of Adults With Pachyonychia Congenita (VALO-2)

Pachyonychia Congenita

United States

3

Subscribe